The 6th edition of the Big Bang Health
Figaro
is dedicated to three essential subjects after two years of health crisis: how to rescue
the
science
French, challenges
of old age
and
the place and future of vaccines
in our care.
Find us every morning from 10:45 a.m. from
November 30 to December 2
in a video event format, broadcast on one of the
Figaro
website
, on our Facebook account and on LinkedIn.
Tuesday 30/11: the Big Bang of French scientific research (from 10:45 a.m. to 12:15 p.m.)
10:45 am: opening interview with
Edith Heard
, geneticist and director of the European Molecular Biology Laboratory (EMBL)
Report: In Bordeaux,
TreeFrog
,
the champion of cell therapy
Debate moderated by Jacques-Olivier Martin: “How to stop the decline of scientific and medical research in France?”, With
Rafaèle Tordjman
, PhD and CEO of Jeito Capital,
Frédéric Collet
, president of Leem, and
Clarisse Angelier
, general delegate of the '' National Association for Research and Technology (ANRT), doctor of materials science
Report: The ISS, a lab above our heads
Yves Thréard's “Talk” receives
Frédérique Vidal
, Minister of Higher Education, Research and Innovation
Wednesday December 1: the Big Bang of old age (10:45 a.m. to 12:15 p.m.)
10:45 am: opening interview with
Chloé Morin
, political scientist, specialist in public opinion
"Opinion" by
Laurent Alexandre
: "How to live 1000 years?"
Report:
Truffle Capital
, behind the scenes of a biotech start-up factory
Report: Tech & robots at the service of nursing homes
Debate moderated by
Marie-Cécile Renault: “Health, well-being, financing, how to meet the challenges of old age?”, With
Luc Broussy,
president of the silver economy sector,
Brigitte Bourguignon
, minister delegate in charge of autonomy, and
Stéphane Junique
, president of the Vyv group
Report: Research progresses in the face of Alzheimer's
Yves Thréard's "Talk" receives
Pascal Bruckner
, philosopher and essayist
Wednesday December 2: the Big Bang of vaccines (from 10:45 a.m. to 12:15 p.m.)
10:45 am: opening interview with
Stéphane Bancel
, CEO of biotech Moderna
Report:
Valneva
, the Nantes biotech that wants to overtake Sanofi
Olivier Babeau's
"Opinion"
: "Should vaccine patents be made public?"
Debate moderated by Tristan Vey on the theme "will the RNA-M vaccine revolutionize health?"
with
Alain Fischer
, Chairman of the Vaccine Strategy Orientation Council,
David Lepoittevin
, Vaccines Activity Director of the French subsidiary of Pfizer, and
Françoise Salvadori
, lecturer in immunology at the University of Burgundy
Report:
Tissium
repairs the tissues of the human body
Yves Thréard's “Talk” receives
Olivier Véran
, Minister of Solidarity and Health
